🔎 Trials Near Me

Home › Ovarian Epithelial Carcinoma › Illinois › Chicago

Ovarian Epithelial Carcinoma clinical trials in Chicago, IL

7 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

RecruitingPhase 2
  • Rush Md Anderson Cancer Center /ID# 274926, Chicago
  • University of Chicago Medical Center /ID# 274796, Chicago
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

RecruitingPhase 3
  • Research Site, Chicago
Ages 18 and older · Women · Updated Jul 21, 2026 · NCT07218809

CT-95 in Advanced Cancers Associated With Mesothelin Expression

RecruitingPhase 1
  • Context Investigational Site, Chicago
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06756035

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

RecruitingPhase 1/2
  • University of Chicago Medical Center, Chicago
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

RecruitingPhase 2
  • University of Chicago Medical Center, Chicago
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775

A Study of NX-1607 in Adults With Advanced Malignancies

RecruitingPhase 1
  • University of Chicago, Chicago
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT05107674

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

RecruitingObservational studyHealthy volunteers welcome
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
Ages 18 to 80 · Women · Updated Feb 28, 2025 · NCT00005095

Ovarian Epithelial Carcinoma trials in other cities

Other studies in Chicago

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.